$QGEN Cashflow Statement | Understand Stock

$QGEN

$50.37 -$0.02 (0.04%) Close

$QGEN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net income
Adjustments to reconcile net income to net cash provided by operating activities, net of effects of businesses acquired:
Depreciation and amortization
Non-cash impairments
Amortization of debt discount and issuance costs
Share-based compensation expense
Deferred tax (benefit) expense
Gain on sale of investment
Reversals of contingent consideration
Loss on marketable securities
Other items, net including fair value changes in derivatives
Net changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Other long-term assets
Accounts payable
Accrued and other current liabilities
Income taxes
Other long-term liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Purchases of property, plant and equipment
Purchases of intangible assets
Purchases of short-term investments
Proceeds from redemptions of short-term investments
Proceeds from divestiture
Cash paid for acquisitions, net of cash acquired
Cash (paid) received for collateral asset
Purchases of investments, net
Other investing activities
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from short-term debt
Repayment of short-term debt
Proceeds from long-term debt, net of issuance costs
Repayment of long-term debt
Payment for termination of warrants
Capital repayment
Tax withholding related to vesting of stock awards
Cash (paid) received for collateral liability
Proceeds from issuance of common shares
Cash paid for contingent consideration
Payment of intrinsic value of cash convertible notes
Proceeds from exercise of call options related to cash convertible notes
Other financing activities
Net cash used in financing activities

Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental cash flow disclosures:
Cash paid for interest
Cash paid for income taxes, net of refunds
Supplemental disclosure of non-cash investing activities:
Equity securities acquired in non-monetary exchange
Intangible asset received in exchange for note receivable

Comments